Get the Stockscreener App
8.35
11.48%
0.86
After Hours:
8.34
-0.010
-0.12%
Emergent Biosolutions Inc stock is traded at $8.35, with a volume of 2.09M.
It is up +11.48% in the last 24 hours and up +0.48% over the past month.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
See More
Previous Close:
$7.49
Open:
$7.37
24h Volume:
2.09M
Relative Volume:
0.66
Market Cap:
$432.32M
Revenue:
$1.02B
Net Income/Loss:
$-757.20M
P/E Ratio:
-0.6912
EPS:
-12.08
Net Cash Flow:
$-257.90M
1W Performance:
+37.79%
1M Performance:
+0.48%
6M Performance:
+230.04%
1Y Performance:
+145.59%
1-Day Range:
$7.31
$8.35
1-Week Range:
$5.69
$8.35
52-Week Range:
$1.42
$15.10
Emergent Biosolutions Inc Stock (EBS) Company Profile
Name
Emergent Biosolutions Inc
Sector
Phone
240-631-3200
Address
400 PROFESSIONAL DR, SUITE 400, GAITHERSBURG, MD
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-17-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-10-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Apr-29-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-20-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-08-21 | Downgrade | The Benchmark Company | Buy → Hold |
| May-05-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Initiated | The Benchmark Company | Buy |
| Feb-24-21 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Feb-19-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-14-20 | Resumed | JP Morgan | Neutral |
| Jul-31-20 | Reiterated | Chardan Capital Markets | Buy |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Sep-04-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-02-18 | Upgrade | Goldman | Neutral → Buy |
| Aug-03-18 | Reiterated | Chardan Capital Markets | Buy |
| Jun-13-18 | Initiated | Argus | Buy |
| Apr-25-18 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Jan-16-18 | Reiterated | Chardan Capital Markets | Buy |
| Jun-28-16 | Reiterated | Singular Research | Buy |
| Apr-15-16 | Initiated | Chardan Capital Markets | Buy |
| Mar-28-16 | Initiated | Singular Research | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| May-15-14 | Initiated | Summer Street Research | Buy |
| May-31-11 | Reiterated | WBB Securities | Strong Buy |
| Jan-10-11 | Reiterated | Wedbush | Outperform |
| Nov-05-10 | Reiterated | Wedbush | Outperform |
| Aug-18-10 | Upgrade | WBB Securities | Buy → Strong Buy |
| Aug-06-10 | Reiterated | Caris & Company | Buy |
View All
Emergent Biosolutions Inc Stock (EBS) Latest News
Emergent Biosolutions lays off 300 people - MSN
Emergent Bio gains after U.S. govt. order for smallpox therapy - MSN
U.S. secures additional smallpox treatments for $67.4 million - Investing.com
Emergent Bio stock gains after U.S. govt. order (NYSE:EBS) - Seeking Alpha
Emergent BioSolutions Shares Rise on U.S. Smallpox-Treatment Order - MarketWatch
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts - The Manila Times
Emergent confirms ~$400 million in orders for smallpox and mpox vaccines - The Pharma Letter
Emergent Sinks on New Orders for Smallpox, Mpox Vaccine - Baystreet.ca
Emergent Bio gains after confirming $400M orders for 2024/25 - MSN
Emergent BioSolutions secures $400M in vaccine orders - Investing.com India
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines - Benzinga
Emergent BioSolutions secures $400M in vaccine orders By Investing.com - Investing.com Australia
Emergent BioSolutions Confirms Approximately $400 Million in Orders in 2024 & 2025 - citybiz
Emergent Biosolutions Shares Rise 16% on Orders Secured for Smallpox, Monkeypox Vaccines - MarketWatch
Emergent BioSolutions secures $400M in vaccine orders - Investing.com
Emergent Bio stock gains after order update (NYSE:EBS) - Seeking Alpha
American Century Companies Inc. Has $6.02 Million Position in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
(EBS) Trading Report - Stock Traders Daily
Police believe the Birmingham, Alabama, mass shooters used ‘conversion devices.’ Here’s what that means - KRDO
Morse Asset Management Inc Makes New $97,000 Investment in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World
Emergent BioSolutions Inc.'s (NYSE:EBS) institutional investors lost 16% last week but have benefitted from longer-term gains - Yahoo Finance
Healthy Upside Potential: Emergent Biosolutions Inc (EBS) - SETE News
U.S. to donate 1M mpox shots to address outbreak in Africa: report - Seeking Alpha
Birmingham, Alabama, leaders plead for information on mass shooting and announce reward money - Cumberland Times-News
A closer look at EBS’s price-to-free cash flow ratio - US Post News
Birmingham, Alabama, leaders plead for information on mass shooting and announce reward money - Idaho Press
Birmingham, Alabama, leaders plead for information on mass shooting and announce reward money - The Caledonian-Record
Market Insights: Emergent Biosolutions Inc (EBS)’s Notable Drop of -6.29, Closing at 6.55 - The Dwinnex
Three victims identified in Birmingham mass shooting as mayor calls for action - MSN
Birmingham mayor speaks as 3 shooting victims identified - NewsNation Now
Birmingham: ‘Our community is grieving’ over 4 dead in shootings | NewsNation Now - MSN
Birmingham, Alabama, police describe mass shooting as targeted 'hit' - Kenosha News
At least 4 killed in mass shooting,17 wounded in nightlife district in Birmingham - Yahoo! Voices
Birmingham PD provides an update after shooting that's left four dead - MSN
Four dead, 18 injured after mass shooting in popular nightlife area of Birmingham, Alabama - MSN
Birmingham officer vows to ‘hunt down’ whoever is responsible for shooting - CNN
United States: 4 people killed and several others injured in mass shooting - TVMnews.mt
Emergent BioSolutions Inc. (NYSE:EBS) Shares Acquired by Federated Hermes Inc. - MarketBeat
Emergent Biosolutions Inc [NYSE: EBS] Sees Increase in Stock Value - Knox Daily
Top NFL Draft prospect suffers season-ending ACL injury - Larry Brown Sports
Beasley Does a Reverse Stock Split - Radio World
Beasley Board Moves Forward With Reverse Stock Split - Radio & Television Business Report
Arbutus Biopharma Co. (NASDAQ:ABUS) Stock Position Lifted by Bank of New York Mellon Corp - Defense World
Emergent BioSolutions Inc. (NYSE:EBS) Short Interest Up 11.0% in August - MarketBeat
Emergent BioSolutions Inc. (NYSE:EBS) Sees Large Growth in Short Interest - Defense World
Acadian Asset Management LLC Has $739,000 Stake in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World
Bank of New York Mellon Corp Increases Stake in Ambev S.A. (NYSE:ABEV) - Defense World
Acadian Asset Management LLC Purchases 79,028 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
Emergent BioSolutions issues equity, sets warrant prices By Investing.com - Investing.com Australia
Emergent BioSolutions issues equity, sets warrant prices - Investing.com
EBS’s Market Balancing Act: Weighing Gains and Losses in 2023 - The InvestChronicle
Emergent Biosolutions Inc Stock (EBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):